<?xml version="1.0" encoding="UTF-8"?>
<ref id="B98-ijerph-17-05904">
 <label>98.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Feldmann</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Maini</surname>
    <given-names>R.N.</given-names>
   </name>
   <name>
    <surname>Woody</surname>
    <given-names>J.N.</given-names>
   </name>
   <name>
    <surname>Holgate</surname>
    <given-names>S.T.</given-names>
   </name>
   <name>
    <surname>Winter</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Rowland</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Richards</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hussell</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed</article-title>
  <source>Lancet</source>
  <year>2020</year>
  <volume>395</volume>
  <fpage>1407</fpage>
  <lpage>1409</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30858-8</pub-id>
  <pub-id pub-id-type="pmid">32278362</pub-id>
 </element-citation>
</ref>
